Financial Performance - Net profit attributable to shareholders decreased by 94.00% to CNY 11,326,073.07 for the first nine months of the year[6]. - Operating revenue for the first nine months decreased by 12.36% to CNY 2,032,929,897.56 compared to the same period last year[6]. - Total profit decreased by 94.36% to ¥14,079,791.81 compared to the same period last year, primarily due to a significant decline in gross profit from glyphosate products[15]. - The company expects a significant decline in net profit for the year compared to the previous year due to the current market conditions for major products like glyphosate[18]. - Net profit for Q3 2015 was a loss of ¥5,087,132.87, compared to a profit of ¥22,976,361.82 in Q3 2014[32]. - Net profit for the period was a loss of approximately ¥9.18 million, compared to a profit of ¥23.05 million in the same period last year, representing a decline of 139.8%[37]. - The total profit for the period was a loss of approximately ¥12.52 million, down from a profit of ¥30.56 million in Q3 2022[36]. Cash Flow and Liquidity - Net cash flow from operating activities decreased by 93.91% to CNY 14,616,780.33 for the first nine months[6]. - The company's cash and cash equivalents decreased by 47.62% to ¥103,624,646.68 compared to the beginning of the period, primarily due to reduced cash inflows from operating activities[11]. - Cash flow from operating activities generated a net amount of approximately ¥14.62 million, a significant decrease from ¥240.20 million in the same period last year[38]. - Total cash and cash equivalents at the end of the period stood at CNY 51,698,774.47, down from CNY 75,302,778.86 at the end of the same period last year[42]. - Cash received from sales of goods and services was CNY 1,579,435,487.62, down 27.7% from CNY 2,185,072,389.01 year-on-year[41]. - Cash paid for dividends and interest was CNY 93,594,675.55, down from CNY 141,391,628.51 in the previous year[42]. Assets and Liabilities - Total assets decreased by 9.98% to CNY 2,958,923,033.02 compared to the end of the previous year[6]. - The company's current assets totaled CNY 808,931,378.02, down from CNY 986,274,251.11 at the beginning of the year, indicating a decrease of about 17.93%[22]. - The total liabilities decreased from CNY 1,953,577,792.31 to CNY 1,675,557,859.53, a reduction of approximately 14.19%[24]. - The company's equity attributable to shareholders decreased from CNY 1,333,205,087.70 to CNY 1,283,365,173.49, reflecting a decline of about 3.74%[24]. - The inventory level decreased significantly from CNY 560,943,917.71 at the beginning of the year to CNY 445,267,298.55, representing a reduction of approximately 20.66%[22]. - Accounts receivable increased from CNY 182,019,067.36 to CNY 191,282,318.00, indicating an increase of about 5.93%[22]. Shareholder Information - The total number of shareholders reached 10,297 at the end of the reporting period[9]. - The largest shareholder, Sinochem International, holds 29.19% of the shares[9]. - The second largest shareholder, Nantong Industrial Holdings, holds 25.79% of the shares, with 25,530,000 shares pledged[9]. - The first and second largest shareholders have committed not to reduce their holdings for six months, and this commitment is still being honored as of the report date[17]. Expenses and Costs - Total operating costs for Q3 2015 were ¥482,405,812.52, down 22.6% from ¥622,738,233.61 in Q3 2014[31]. - Sales expenses increased to approximately ¥39.14 million, up from ¥36.44 million in the previous year, reflecting an increase of 7.4%[36]. - Management expenses decreased to approximately ¥106.99 million, down 24.7% from ¥141.93 million in the same period last year[36]. - Financial expenses rose to approximately ¥29.38 million, compared to ¥36.74 million in the previous year, indicating a decrease of 20.0%[36]. Investment and Income - The company's investment income decreased by 81.54% to ¥1,761,139.45, mainly due to a decline in profits from the joint venture Nantong Dongchang Chemical Co., Ltd.[15]. - Investment income showed a loss of approximately ¥1.38 million, contrasting with a profit of ¥1.22 million in Q3 2022[36].

Financial Performance - The company's operating revenue for the first half of 2015 was ¥1,562,811,407.69, a decrease of 6.33% compared to ¥1,668,379,911.08 in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2015 was ¥16,413,205.94, representing a significant decline of 90.10% from ¥165,815,922.28 in the previous year[18]. - The net cash flow from operating activities was ¥10,377,635.72, down 95.76% from ¥244,802,941.27 in the same period last year[18]. - The total assets at the end of the reporting period were ¥3,044,205,210.77, a decrease of 7.38% from ¥3,286,782,880.01 at the end of the previous year[18]. - The net assets attributable to shareholders decreased by 3.37% to ¥1,288,235,704.26 from ¥1,333,205,087.70 at the end of the previous year[18]. - Basic earnings per share for the first half of 2015 were ¥0.0829, down 90.10% from ¥0.8375 in the same period last year[19]. - The weighted average return on net assets was 1.33%, a decrease of 11.49 percentage points from 12.82% in the previous year[19]. - The company's gross profit margin was 9.13%, a decrease of 12.58 percentage points compared to the previous year[30]. - The company's pesticide business reported revenue of ¥1,156,696,629.60, a year-over-year decrease of 8.06%, with a gross margin decline of 18.15 percentage points to 3.31%[35]. - The company expects a significant decline in cumulative net profit for the year compared to the previous year, with a net profit of ¥16,413,200 for the first half of 2015, down 90.10% year-over-year[48]. Revenue Composition - The average selling price of glyphosate products dropped over 30% compared to the same period last year, significantly impacting overall revenue[25]. - Gross profit from non-glyphosate products reached CNY 140.69 million, representing a year-on-year increase of 33.75%[26]. - The proportion of glyphosate products in total revenue decreased from 61.35% to 54.48% year-on-year[26]. - Domestic revenue reached ¥1,027,322,415.38, reflecting a growth of 13.75%, while international revenue fell to ¥535,488,992.31, a decline of 29.45%[37]. Cash Flow and Investments - Operating cash flow for the period was CNY 10.38 million, a significant drop of 95.76% from CNY 244.80 million in the previous year[28]. - The company has not made any external equity investments during the reporting period[40]. - The company borrowed 9.5 billion RMB from Sinochem Group Finance Co., Ltd. during the reporting period, with a repayment of the same amount, resulting in a year-end balance of 0 RMB[53]. - The company paid a total of 3,673,531.25 RMB in interest on the borrowed funds during the reporting period[53]. Related Party Transactions - There were no significant non-operating fund occupation issues by controlling shareholders or related parties[3]. - The total amount of related party transactions was 1,714,097.20 RMB, indicating a low dependency on related parties for business operations[55]. - Related party transactions accounted for a small proportion of the company's overall business, with amounts below 0.5% of the audited net assets at the end of the previous year[56]. - The company engaged in related party transactions based on market pricing principles, with no significant price differences observed[56]. Shareholder Information - The total number of shareholders at the end of the reporting period was 10,337[63]. - The largest shareholder, Sinochem International Corporation, held 29.19% of the shares, totaling 57,789,418 shares[64]. - The second-largest shareholder, Nantong Industrial Holdings Group Co., Ltd., held 25.79% of the shares, totaling 51,072,918 shares[64]. Assets and Liabilities - The total current assets decreased from CNY 986,274,251.11 to CNY 837,160,673.55, a reduction of approximately 15.1%[75]. - The company's cash and cash equivalents decreased from CNY 197,829,103.94 to CNY 119,187,723.76, a decline of about 39.8%[75]. - Total liabilities decreased from CNY 1,953,577,792.31 to CNY 1,755,969,506.51, a reduction of approximately 10.1%[76]. - The total equity attributable to the parent company decreased from CNY 1,333,205,087.70 to CNY 1,288,235,704.26, a decline of about 3.4%[77]. Accounting Policies and Compliance - The company has not made any changes to its accounting policies or estimates during the reporting period[60]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring the financial statements reflect a true and complete picture of its financial status[112]. - The company’s accounting period follows the calendar year, from January 1 to December 31, ensuring consistency in reporting[113]. Impairment and Provisions - The company conducts annual impairment tests for goodwill, requiring estimates of future cash flows and appropriate discount rates[197]. - The company recognizes impairment losses for loans and receivables based on the present value of expected future cash flows[136]. - The company estimates and recognizes provisions for product quality guarantees and potential contract losses based on historical experience and current obligations[200]. Fair Value Measurements - The company’s fair value measurements for certain assets and liabilities are determined using observable market data or qualified external appraisers when necessary[200]. - The valuation committee, led by the CFO, reports quarterly to the board on fair value fluctuations and the reasons behind them[200].

Financial Performance - Operating revenue for the period was CNY 809,612,733.76, a decline of 6.15% year-on-year[6] - Net profit attributable to shareholders decreased by 91.15% to CNY 8,518,765.24 compared to the same period last year[6] - Basic and diluted earnings per share dropped by 91.15% to CNY 0.0430[6] - Total profit for the period was CNY 14,238,280.45, down 88.75% compared to CNY 126,587,369.57 in the previous year, mainly due to a decrease in gross profit from glyphosate products[12] - Investment income decreased by CNY 3,615,797.52, a decline of 68.58%, primarily due to reduced profits from the associated company Nantong Dongchang Chemical Co., Ltd.[12] - Net profit for Q1 2015 was CNY 8,518,765.24, a significant decline of 91.16% compared to CNY 96,231,015.44 in Q1 2014[26] - The company's operating revenue for the current period is ¥742,966,561.76, a decrease of 13.7% compared to ¥861,693,266.55 in the previous period[29] - The net profit for the current period is ¥7,011,493.74, down 92.7% from ¥96,173,709.55 in the previous period[30] - The operating profit has significantly declined to ¥9,391,266.86, compared to ¥124,691,252.63 in the previous period, reflecting a decrease of 92.5%[29] Cash Flow - Cash flow from operating activities showed a significant decline of 161.18%, resulting in a net outflow of CNY 39,443,296.32[6] - The net cash flow from operating activities was CNY -39,443,296.32, a decrease of 161.18% compared to CNY 64,467,000.55 in the previous year, mainly due to reduced cash received from sales and increased cash paid to employees[13] - The cash flow from operating activities shows a net outflow of ¥39,443,296.32, contrasting with a net inflow of ¥64,467,000.55 in the previous period[33] Assets and Liabilities - Total assets decreased by 5.09% to CNY 3,119,410,534.91 compared to the end of the previous year[6] - The total assets as of March 31, 2015, were CNY 3,119,410,534.91, down from CNY 3,286,782,880.01 at the beginning of the year[19] - The total liabilities decreased from CNY 1,953,577,792.31 to CNY 1,777,668,074.13 during the same period[20] - Current liabilities decreased to CNY 1,569,803,105.13 from CNY 1,748,106,124.80, a reduction of 10.23%[23] - Total liabilities decreased to CNY 1,686,818,505.60 from CNY 1,867,869,548.45, a decrease of 9.66%[24] Shareholder Information - The number of shareholders at the end of the reporting period was 13,823[9] - The largest shareholder, Sinochem International, holds 29.19% of the shares, totaling 57,789,418 shares[9] Cash and Cash Equivalents - The company reported a 31.84% decrease in cash and cash equivalents, down to CNY 134,833,762.34[10] - Cash and cash equivalents dropped to CNY 84,304,570.91 from CNY 193,851,633.76, a decrease of 56.54%[22] - The total cash and cash equivalents at the end of the period is ¥98,652,623.09, a decrease from ¥89,000,511.32 in the previous period[34] - The cash and cash equivalents at the end of the period were $48,123,431.66, down from $88,649,263.13 in Q1 2014[35] - The cash and cash equivalents decreased by $78,023,211.35 during the quarter, compared to a decrease of $44,969,972.68 in the previous year[35] Prepayments and Receipts - Prepayments increased by 187.88% to CNY 23,117,293.54 compared to the beginning of the year[10] - The company experienced a 41.37% decrease in advance receipts, totaling CNY 125,722,057.76[10] - The ending balance of prepaid expenses increased by CNY 15,086,985.86, a growth of 187.88%, mainly due to increased prepayments for raw materials during the reporting period[11] - The ending balance of advance receipts decreased by CNY 88,719,510.93, a decline of 41.37%, primarily because the advance payments for pesticides from the previous year's fourth quarter were recognized as sales in this reporting period[11] Operating Costs - Total operating costs increased to CNY 800,015,641.03, up 7.67% from CNY 743,087,973.81 in the same period last year[25] - The company incurred a total operating cost of ¥677,356,941.99, slightly up from ¥672,392,018.62 in the previous period[29] Financial Expenses and Income Tax - The financial expenses decreased to ¥11,438,199.55 from ¥15,890,358.38, indicating a reduction of 28.9%[29] - The income tax expense decreased significantly to ¥5,320,538.40 from ¥30,300,562.36, a reduction of 82.4%[29]

Financial Performance - The company achieved a total revenue of CNY 2,975,916,721.05 in 2014, representing a decrease of 5.9% compared to CNY 3,162,572,050.32 in 2013[34]. - Net profit attributable to shareholders was CNY 201,759,257.27, down 33.24% from CNY 302,209,820.78 in the previous year[34]. - The basic earnings per share decreased to CNY 1.0190, a decline of 33.24% from CNY 1.5263 in 2013[26]. - The company reported a net cash flow from operating activities of CNY 417,342,781.29, down 34.91% from CNY 641,225,421.66 in 2013[36]. - Total operating costs amounted to CNY 2,733,336,198.94, down from CNY 2,810,297,277.70, reflecting a cost reduction strategy[187]. - Operating profit decreased to CNY 254,833,112.02, compared to CNY 383,228,457.03 in the previous year, indicating a decline of 33.5%[187]. - Net profit for the year was CNY 260,900,083.87, down from CNY 387,823,681.58, representing a decrease of 32.7%[187]. - The company reported a decrease in financial expenses to CNY 49,485,000.26, down 43.0% from CNY 86,896,096.44 in the previous year[190]. Shareholder Information - The company plans to distribute a cash dividend of 3.1 RMB per 10 shares, totaling 61,380,000 RMB for the year 2014[3]. - The total share capital of the company at the end of 2014 was 198,000,000 shares[3]. - The first major shareholder, Sinochem International, holds 29.19% of the company's shares, while Nantong Industrial Holding Group is the second major shareholder[20]. - The company maintained a stable relationship with its major shareholders, with no penalties or public criticisms from regulatory bodies during the year[106]. - The total number of shareholders at the end of the reporting period was 17,687, compared to 14,045 five trading days prior, indicating a growth of approximately 25.0%[117]. Operational Efficiency - The company has implemented a lean management strategy to enhance operational efficiency and reduce costs, focusing on dynamic production scheduling and capacity utilization[56]. - The company aims to enhance production capacity utilization through lean management and better coordination of supply and production, focusing on chlor-alkali, pesticides, and chemical intermediates[81]. - The production director indicated a production capacity utilization rate of 57% for the year[131]. - The company reported a significant increase in revenue, achieving a total of $1.5 billion for the fiscal year, representing a 15% year-over-year growth[132]. Market and Product Development - The company plans to enhance its market competitiveness by improving management practices and accelerating strategic development[34]. - The company is exploring potential mergers and acquisitions to enhance its market share and product offerings[131]. - The company plans to increase its core product contributions to offset the decline in glyphosate market demand in 2015[80]. - The company is positioned to benefit from government policies promoting the development of environmentally friendly pesticides[78]. - The company launched new products, including a 450g/l glyphosate water agent that generated sales revenue of 62.10 million yuan[40]. Risk Management - The company has detailed risks related to industry policy changes, market fluctuations, and raw material price volatility in its report[9]. - The company recognizes market volatility as a significant risk, particularly in glyphosate pricing, and plans to optimize product structure and improve production efficiency to mitigate this risk[83]. - The company emphasizes the importance of investment risk awareness in its forward-looking statements[4]. Research and Development - Research and development expenses increased by 10.18% to CNY 11,074,715.05 compared to CNY 10,051,175.50 in 2013[36]. - The company is investing in research and development, allocating 70.53 million towards innovative solutions[131]. - The company is investing $50 million in research and development for new technologies aimed at enhancing product efficiency[132]. Environmental and Safety Compliance - The company has not reported any environmental pollution incidents during the reporting period, demonstrating compliance with environmental regulations[93]. - The company achieved compliance with all major environmental KPIs and maintained normal operation of key pollution control facilities, resulting in a "blue" environmental credit rating for the year[94]. - The company is committed to improving safety management and has implemented the DuPont safety management system to ensure safe production operations[81]. Financial Health - The company's total assets at the end of 2014 were CNY 3,286,782,880.01, a slight decrease of 1.66% from CNY 3,342,387,802.94 in 2013[34]. - The total liabilities decreased from CNY 2,116,478,366.93 to CNY 1,953,577,792.31 during the reporting period[180]. - The company's total equity increased from CNY 1,225,909,436.01 to CNY 1,333,205,087.70, reflecting a growth of approximately 8.8%[181]. Governance and Management - The company has established a governance structure that complies with relevant laws and regulations, with no issues requiring regulatory rectification[151]. - The total remuneration for the chairman, Li Dajun, was 0 million yuan (pre-tax) during the reporting period[130]. - The total remuneration for the general manager, Xue Jian, was 123.73 million yuan (pre-tax) during the reporting period[130]. - The company’s board of directors and supervisors underwent changes, including the election of new independent directors and supervisors[138].

Financial Performance - Net profit attributable to shareholders decreased by 19.44% to CNY 188,792,284.10 for the first nine months of the year[5] - Operating revenue for the first nine months decreased by 4.73% to CNY 2,319,520,004.89 compared to the same period last year[5] - Basic earnings per share decreased by 19.44% to CNY 0.9535[6] - Total operating revenue for Q3 2014 was CNY 651,140,093.81, a decrease of 7.1% compared to CNY 701,277,567.70 in Q3 2013[26] - Net profit for Q3 2014 was CNY 22,976,361.82, down 77.7% from CNY 103,124,860.02 in Q3 2013[27] - Total profit for the first nine months of 2014 was CNY 249,606,366.68, compared to CNY 304,119,366.18 in the previous year, reflecting a decrease of 18%[27] Cash Flow - Net cash flow from operating activities decreased by 48.74% to CNY 240,204,424.73 for the first nine months[5] - The net cash flow from operating activities for the first nine months was ¥240,204,424.73, a decrease of 48.7% compared to ¥468,632,806.94 in the same period last year[33] - Cash received from the sale of goods and services was ¥2,025,829,380.80, down 6.4% from ¥2,165,837,079.42 year-on-year[33] - The total cash inflow from operating activities was ¥2,055,578,239.80, compared to ¥2,184,672,022.12 in the previous year, reflecting a decline of 5.9%[33] - The company reported a total cash outflow from operating activities of ¥1,815,373,815.07, compared to ¥1,716,039,215.18 last year, an increase of 5.8%[33] Assets and Liabilities - Total assets decreased by 6.72% to CNY 3,122,701,531.99 compared to the end of the previous year[5] - Cash and cash equivalents decreased by 45.14% to ¥150,507,032.64 from ¥274,338,651.18 due to increased loan repayments during the reporting period[9] - Total liabilities decreased from CNY 2,124,900,752.73 to CNY 1,844,601,791.23, representing a reduction of about 13.2%[23] - Current liabilities decreased from CNY 2,005,726,904.87 to CNY 1,731,740,963.71, a decrease of approximately 13.6%[23] - The total liabilities to total assets ratio improved from approximately 63.6% to 58.3%[23] Shareholder Information - The total number of shareholders reached 18,747 by the end of the reporting period[6] - The largest shareholder, Sinochem International, holds 29.19% of the shares, totaling 57,789,418 shares[7] - The second largest shareholder, Nantong Industrial Holdings, holds 26.54% of the shares, totaling 52,544,718 shares[7] Other Financial Metrics - The company reported a loss of CNY 3,212,127.40 from the disposal of non-current assets during the reporting period[6] - Government subsidies recognized in the current period amounted to CNY 3,704,523.18[6] - Investment income decreased by 61.89% to ¥9,537,878.23 from ¥25,024,821.88, primarily due to a decline in profits from the associated company Nantong Shidongchang Chemical Co., Ltd.[9] - The company reported a significant increase in other operating expenses, which rose by 396.55% to ¥6,599,222.64 from ¥1,329,009.08, mainly due to increased net losses from fixed asset disposal[9] - Management expenses increased to CNY 143,095,882.26 in the first nine months of 2014, compared to CNY 140,100,935.73 in the previous year[26]

Financial Performance - The company's operating revenue for the first half of 2014 was ¥1,668,379,911.08, a decrease of 3.75% compared to ¥1,733,414,996.16 in the same period last year[18]. - The net profit attributable to shareholders was ¥165,815,922.28, representing an increase of 26.37% from ¥131,214,573.17 year-on-year[18]. - The net cash flow from operating activities decreased by 47.68% to ¥244,802,941.27, down from ¥467,871,297.42 in the previous year[18]. - The total assets at the end of the reporting period were ¥3,113,154,271.27, a decrease of 4.87% from ¥3,272,596,028.60 at the end of the previous year[18]. - The net assets attributable to shareholders increased by 6.01% to ¥1,283,012,367.76 from ¥1,210,240,367.13 at the end of the previous year[18]. - Basic earnings per share rose to ¥0.8375, up 26.37% from ¥0.6627 in the same period last year[19]. - The weighted average return on net assets was 12.8227%, a slight decrease of 0.3139 percentage points compared to 13.1366% in the previous year[19]. - The company reported a total of ¥1,888,709.71 in non-recurring gains and losses for the period[20]. Revenue Breakdown - Revenue from pesticide products was RMB 1.258 billion, an increase of 6.61% year-on-year, while chemical products revenue decreased by 48.32% to RMB 160 million[25]. - Domestic revenue reached ¥903,130,184.70, an increase of 13.45% compared to the previous year[33]. - International revenue was ¥759,029,013.41, a decrease of 18.61% compared to the previous year[33]. Expenses and Costs - Sales expenses decreased by 21.05% to RMB 25 million, while management expenses decreased by 8.88% to RMB 89 million[24]. - The company reported a significant reduction in financial expenses by 49.86% to RMB 26 million, attributed to decreased exchange losses and lower bank loan interest[24]. - Research and development expenses were RMB 4.8 million, a decrease of 18.49% as the focus shifted to optimizing existing technologies[24]. - Total operating costs decreased to CNY 1,460,344,045.56, down 8.01% from CNY 1,587,326,331.06 in the previous year[65]. Cash Flow and Financing - The net cash flow from financing activities was -¥234,012,469.31, compared to -¥383,707,067.54 in the same period last year, indicating an improvement[72]. - The total cash inflow from financing activities was ¥2,721,661,543.50, down 22.3% from ¥3,501,913,800.00 in the previous year[72]. - The cash flow from investment activities was negative at -¥34,836,295.46, indicating a decrease in investment cash inflow compared to the previous year[75]. Shareholder Information - The company distributed cash dividends of ¥93,060,000, amounting to ¥4.7 per 10 shares based on a total share capital of 198,000,000 shares[36]. - Total number of shareholders at the end of the reporting period is 16,167[51]. - The largest shareholder, Sinochem International Corporation, holds 29.19% of shares, totaling 57,789,418 shares[52]. - The second largest shareholder, Nantong Industrial Holding Group, holds 26.54% of shares, totaling 52,544,718 shares[52]. Assets and Liabilities - The company's total current assets decreased from 934,578,509.42 RMB at the beginning of the year to 861,048,842.12 RMB at the end of the reporting period, a decrease of approximately 7.8%[59]. - Total liabilities decreased from CNY 2,062,355,661.47 to CNY 1,830,141,903.51, a reduction of approximately 11.2%[60]. - Cash and cash equivalents decreased from CNY 270,797,398.48 to CNY 196,551,776.70, a decline of about 27.4%[62]. - Accounts receivable increased from CNY 123,898,268.96 to CNY 150,965,174.82, an increase of approximately 21.9%[62]. Inventory and Receivables - The total inventory at the end of the period is 445,831,798.59, with a provision for decline in value of 6,934,832.30, leading to a net book value of 438,896,966.29[199]. - The accounts receivable at the end of the period amounted to RMB 162,456,376.35, with a bad debt provision of RMB 9,379,700.91, representing 5.77% of the total[185]. - The company’s accounts receivable aging analysis shows that 92.58% of the receivables are within one year[185]. Accounting Policies and Estimates - The company has not changed its major accounting policies during the reporting period[165]. - The company has not changed its major accounting estimates during the reporting period[166]. - The company assesses the recoverability of accounts receivable based on management's judgment and estimates, which may affect the carrying value of accounts receivable and the provision for bad debts[166]. Regulatory Compliance - The financial report for the first half of 2014 has not been audited[5]. - The company’s financial statements are prepared based on the going concern assumption and comply with the relevant accounting standards issued by the Ministry of Finance[91]. - The company’s financial reports reflect its financial position and operating results as of June 30, 2014, in accordance with the disclosure requirements of the China Securities Regulatory Commission[92].

Financial Performance - The corrected weighted average net asset return for the first half of 2014 is 12.6766%, a decrease of 0.1212 percentage points compared to the same period last year[1] - The total comprehensive income and the comprehensive income attributable to the parent company were both corrected to ¥165,845,449.39 from the previous ¥165,815,922.28[1] Investor Relations - The company acknowledges the inconvenience caused to investors due to the corrections and commits to improving the quality of information disclosure in future reports[2]

Financial Performance - Net profit attributable to shareholders increased by 84.00% to CNY 96,231,015.44, compared to CNY 52,298,562.40 in the same period last year[8] - Basic earnings per share rose by 84.02% to CNY 0.4860, compared to CNY 0.2641 in the same period last year[8] - The weighted average return on equity increased by 2.23 percentage points to 7.65%[8] - Net profit for Q1 2014 reached CNY 96,231,015.44, representing a significant increase of 83.96% compared to CNY 52,298,562.40 in Q1 2013[27] - Operating profit for Q1 2014 was CNY 124,809,793.84, which is a 95.41% increase from CNY 63,934,975.11 in Q1 2013[27] Revenue and Costs - Operating revenue slightly increased by 0.47% to CNY 862,625,745.18, compared to CNY 858,571,398.23 in the same period last year[8] - Total operating revenue for Q1 2014 was CNY 862,625,745.18, a slight increase of 0.15% compared to CNY 858,571,398.23 in the same period last year[27] - Total operating costs decreased to CNY 743,087,973.81, down 7.76% from CNY 805,587,113.19 in Q1 2013[27] Cash Flow - Net cash flow from operating activities decreased significantly by 72.69% to CNY 64,467,000.55, compared to CNY 236,054,515.33 in the same period last year[8] - Cash flow from operating activities was CNY 64,467,000.55, a decrease of 72.69% compared to CNY 236,054,515.33 in Q1 2013[32] - Cash inflow from operating activities totaled ¥777,517,739.59, down 4.0% from ¥809,682,883.50 year-on-year[36] - Cash outflow from operating activities increased to ¥649,271,440.34, up 22.7% from ¥529,406,578.89 in the previous year[36] Assets and Liabilities - Total assets decreased by 2.34% to CNY 3,195,962,470.08 compared to the end of the previous year[8] - Current liabilities decreased from ¥2,005,028,035.21 to ¥1,833,645,169.39, reflecting a reduction in short-term borrowings and accounts payable[21] - The company's total liabilities decreased from ¥2,062,355,661.47 to ¥1,889,480,284.53, indicating a reduction in financial leverage[21] - Shareholders' equity increased to CNY 1,295,274,990.81, up from CNY 1,199,101,281.26, marking an increase of 8.02%[26] Investments and Expenses - The company reported a significant increase in income tax expenses by 120.04% to CNY 30,356,354.13 compared to CNY 13,795,568.30 in the same period last year[15] - Financial expenses decreased by 46.40% to CNY 15,898,080.68, attributed to a reduction in total loans and lower average interest rates[16] - The company reported an investment income of CNY 5,272,022.47, down from CNY 10,950,690.07 in the previous year, a decline of 51.85%[27] Shareholder Information - The number of shareholders totaled 14,560, with the largest shareholder holding 29.19% of shares[12] Inventory and Receivables - The accounts receivable increased from ¥124,015,787.18 to ¥152,427,716.88, indicating a rise in credit sales[20] - The inventory decreased from ¥469,642,413.02 to ¥446,063,113.11, suggesting improved inventory management[20] - The company experienced a 40.95% decrease in notes receivable, totaling CNY 21,511,060.71, primarily due to increased accounts payable[13]

Financial Performance - The company reported a basic earnings per share of 1.5293 CNY, an increase of 808.67% compared to 0.1683 CNY in 2012[27]. - The diluted earnings per share also stood at 1.5293 CNY, reflecting the same significant increase of 808.67% from the previous year[27]. - The weighted average return on equity reached 28.33%, up from 3.62% in 2012, marking a substantial increase of 24.71 percentage points[27]. - In 2013, the company achieved operating revenue of RMB 3.16 billion, a year-on-year increase of 5.14%[34]. - The net profit attributable to shareholders reached RMB 302.79 million, reflecting a significant increase of 808.75% compared to the previous year[34]. - The net cash flow from operating activities was RMB 641.23 million, up 41.31% year-on-year[34]. - The company's total assets at the end of 2013 were RMB 3.27 billion, a slight increase of 0.89% from the previous year[34]. - The net assets attributable to shareholders increased by 28.95% to RMB 1.21 billion by the end of 2013[34]. - The total sales gross profit amounted to 741 million yuan, with an average gross profit margin of 23.42%, up by 10.84 percentage points year-on-year[55]. - The company achieved a net profit attributable to shareholders of 302.79 million yuan, representing a year-on-year increase of 808.75%[55]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 4.7 CNY per 10 shares, totaling 93,060,000 CNY, based on the total share capital of 198,000,000 shares as of the end of 2013[5]. - The company plans to distribute a cash dividend of 4.7 RMB per 10 shares, totaling 93,060,000 RMB, which represents 30.73% of the net profit attributable to shareholders for 2013[89]. - The company has implemented a cash dividend policy, distributing 31,680,000 RMB in 2012, which was higher than the stipulated distribution ratio in the articles of association[88]. - The largest shareholder, Sinochem International Corporation, holds 29.19% of shares, totaling 57,789,418 shares[119]. - The second-largest shareholder, Nantong Industrial Holding Group Co., Ltd., holds 26.54% of shares, totaling 52,544,718 shares, with a decrease of 3,781,559 shares during the reporting period[119]. - The total number of shareholders at the end of the reporting period was 14,517, while it was 14,996 five trading days before the report disclosure[117]. Business Operations and Market Position - The company’s main business remains the production and sales of agrochemical products, with no changes since its listing[20]. - The pesticide business generated revenue of RMB 2.16 billion, a growth of 22.8% year-on-year, primarily driven by increased sales of glyphosate[38]. - The chemical business revenue decreased by 21.02% to RMB 515 million, largely due to the exclusion of revenue from a consolidated subsidiary in the previous year[38]. - The company ranked 10th in pesticide sales revenue among the top 100 pesticide companies in China for 2013[65]. - The company has established a complete industrial chain and upgraded its production facilities, enhancing its manufacturing capabilities and competitiveness[66]. - The company has a strong research and development capability, with several advanced production processes and technologies recognized at the national level[66]. Risk Management and Compliance - The company has detailed risks related to industry policy changes, market fluctuations, and raw material price volatility in its reports[10]. - The company faces safety risks due to the handling of flammable, explosive, and toxic materials during production, and is enhancing safety management practices[86]. - Environmental risks are present due to the generation of waste during pesticide production, and the company is increasing investments in environmental protection measures[86]. - The company is exposed to market volatility risks, particularly in glyphosate pricing, which has fluctuated significantly in recent years[87]. - The company has not faced any major litigation or arbitration issues during the reporting period[97]. - The company has committed to enhancing its environmental management capabilities to mitigate risks associated with industry policy changes[86]. Management and Governance - The company has seen a significant turnover in its board members, with several key positions held by individuals with extensive experience in the chemical industry[133][134][135]. - The company appointed a new board of directors and supervisory board members on January 27, 2014, including Li Dajun as chairman and Xue Jian as general manager[139]. - The company has been focusing on enhancing its governance structure with the election of new board members and supervisors to improve operational efficiency[139]. - The total remuneration payable to directors, supervisors, and senior management during the reporting period amounted to 6.409141 million yuan[144]. - The actual remuneration received by directors, supervisors, and senior management during the reporting period totaled 5.7373 million yuan, which includes the basic annual salary and performance bonuses based on 2012 performance assessments[144]. Research and Development - Research and development expenses decreased by 33.71% to RMB 100.51 million, focusing on technology improvements and environmental upgrades[37]. - The company plans to enhance its production and technical innovation capabilities, focusing on product optimization and waste management technology[52]. - The company has a total of 21 employees with a master's degree or above, and 1,018 employees with education below the college level[147]. Financial Position and Cash Flow - Cash and cash equivalents increased by 68.34% to approximately ¥274.34 million, primarily due to increased profits and higher deposit balances[61]. - Short-term borrowings decreased by 41.08% to approximately ¥982.30 million, attributed to the issuance of short-term financing bonds and significant cash inflows from operating activities[62]. - The company reported a significant increase in retained earnings, which rose to RMB 668,932,518.51 from RMB 427,681,051.06, an increase of approximately 56.4%[183]. - The company incurred a net cash outflow from financing activities of CNY 519,763,539.43, compared to a net outflow of CNY 455,631,572.47 in the previous year[196].